Natco Pharma Ltd receives 8 observations from USFDA for Pharma Division at Kothur

Natco Pharma Limited has announced the completion of an inspection by the United States Food and Drug Administration (USFDA) for its Pharma Division located in Kothur Hyderabad, India, which was conducted from 9th October, 2023 to 18th October, 2023.

At the end of the inspection, the facility received Eight (8) observations. The company is confident of addressing all the observations within the stipulated time and working with USFDA to close them at the earliest.

Shares of Natco Pharma Limited was last trading in BSE at Rs. 833.75 as compared to the previous close of Rs. 844.50. The total number of shares traded during the day was 4817 in over 557 trades.

The stock hit an intraday high of Rs. 858.40 and intraday low of 832.00. The net turnover during the day was Rs. 4048968.00.

Source : Equity Bulls

Keywords

NatcoPharma INE987B01026 USFDA Inspection 8Observations PharmaDivision Kothur Hyderabad